相关实验视频

Updated: Jun 4, 2025

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

进化黑色素瘤的预后生物标志物免疫疗法

Robin Reschke^1,2, Alexander H Enk³, Jessica C Hassel^3,4

¹Medical Faculty Heidelberg, Department of Dermatology and National Center for Tumor Diseases (NCT), Heidelberg University, NCT Heidelberg, a partnership between DKFZ and University Hospital Heidelberg, Heidelberg, Germany. RobinNiklas.Reschke@med.uni-heidelberg.de.

American journal of clinical dermatology

|December 20, 2024

概括

确定可靠的生物标志物对于有效的黑色素瘤免疫疗法至关重要. 本综述涵盖了PD-L1,TMB和ctDNA等既定和新兴的标记物,以个性化皮肤癌治疗.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
皮肤病学皮肤病学

背景情况:

黑色素瘤免疫疗法有先进的治疗方法,但显示出患者反应的变化.
需要可靠的生物标志物来指导黑色素瘤患者个性化治疗决策.

研究的目的:

审查黑色素瘤免疫疗法的既定和新兴生物标志物.
讨论生物标志物在个性化治疗中的作用以及未来的研究方向.

主要方法:

在黑色素瘤免疫治疗中关键生物标志物的文献综述.
探索已确定的标记物:PD-L1表达,瘤突变负担 (TMB),基因表达特征 (GEP).
研究新出现的标记物:LAG-3表达,免疫细胞表型,肠道微生物群,循环瘤DNA (ctDNA).

主要成果:

PD-L1,TMB和GEP是已建立的关键生物标志物.
像ctDNA这样的新兴生物标志物显示出希望,可能预测对诸如tebentafusp. tebentafusp.等药物的反应.
生物标志物对于定制免疫疗法和指导未来研究,包括新辅助剂策略至关重要.

结论:

生物标志物对于优化黑色素瘤免疫治疗结果至关重要.
像ctDNA这样的新兴生物标志物为治疗个性化提供了新的途径.
未来的研究应该专注于将这些生物标志物纳入临床实践,并探索新的治疗方法.

更多相关视频

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...